BioSpace News Archive

Ceapro Inc. Reports Preliminary Results from Clinical Trial Evaluating Oat Beta Glucan in Patients with High Cholesterol Levels

Ceapro Inc. today reported preliminary results from the clinical study evaluating Oat Beta Glucan.

November 17, 2021
·
3 min read
FDA

Zentalis Pharmaceuticals Announces Fast Track Designation Granted by the U.S. FDA to ZN-c3 for the Treatment of Uterine Serous Carcinoma

Zentalis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZN-c3, the Company’s oral WEE1 inhibitor product candidate.

November 17, 2021
·
4 min read
Drug Development

Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2 Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

Eloxx Pharmaceuticals, Inc. today announced positive topline results from the monotherapy arms of its Phase 2 clinical trial of ELX-02 in Class 1 cystic fibrosis (CF) patients with at least one G542X nonsense allele mutation.

November 17, 2021
·
9 min read
New White Paper Highlights Barriers and Opportunities to Drive Biosimilar Adoption in the United States

Biologic medicines are among the most innovative drugs to treat many life-threatening conditions, including cancer and autoimmune diseases.

November 17, 2021
·
5 min read
Pharm Country

NURTEC® ODT Approved In Kuwait For Acute Treatment Of Migraine

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven”) announced today that NURTEC® ODT (rimegepant) was approved by the Kuwait Ministry of Health for the acute treatment of migraine with and without aura in adults.

November 17, 2021
·
7 min read
Genetown

Boston Children’s Hospital to co-lead a 25-center NIH-funded study of brain development from birth to age 10

Study will investigate how a broad range of exposures affect brain and child development.

November 17, 2021
·
3 min read
Business

mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity Capabilities

mRNA Victoria and Ginkgo Bioworks today announced a partnership to support vaccine development, biosecurity nitiatives, and the application to Ginkgo’s platform in the pharmaceutical and biotech, food and agriculture, and mining and bioremediation/recycling sectors in Australia.

November 17, 2021
·
6 min read
Business

Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors

Heidi Hunter, accomplished healthcare leader and President of Cardinal Health Specialty Solutions, to bring additional global biopharma strategic and operational expertise to Sutro’s Board.

November 17, 2021
·
6 min read
Business

Castle Biosciences Named in Inc.’s First-Annual Best-Led Companies

Castle Biosciences, Inc. today announced that it has been named in Inc.’s first-annual Best-Led Companies list, a select, data-driven list of the very strongest U.S. firms with revenue of $50 million to $2 billion.

November 17, 2021
·
5 min read
FDA

Prilenia Receives Fast Track Designation for Pridopidine for the Treatment of Huntington’s Disease

Prilenia Therapeutics B.V. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pridopidine for development as a potential treatment for Huntington’s Disease (HD).

November 17, 2021
·
4 min read